Features of CFTR mRNA and implications for therapeutics development

Area of Science:

• Molecular Biology
• Genetics
• RNA Biology

Background:

• Cystic fibrosis (CF) is a genetic disorder caused by mutations in the CF transmembrane conductance regulator (CFTR) gene.
• Current modulator therapies benefit many CF patients, but some individuals show no response or adverse reactions.
• New therapeutic strategies are needed for patients with rare or refractory CFTR variants, especially those with truncated CFTR protein.

Purpose of the Study:

• To review CFTR mRNA features impacting protein function and explore RNA-directed therapies.
• To discuss how mRNA elements influence splicing, stability, and post-transcriptional regulation.
• To highlight the importance of CFTR RNA biology for future CF treatments.

Main Methods:

• Literature review of CFTR mRNA features and their functional consequences.
• Analysis of alternative exon usage, polypyrimidine tracts, and 5'-untranslated region elements.
• Examination of mRNA decay mechanisms, 3'-untranslated region interactions, and synonymous single nucleotide polymorphisms.

Main Results:

• CFTR mRNA contains regulatory elements (e.g., alternative exons, polypyrimidine tracts, 3'-UTR sequences) affecting splicing, stability, and translation.
• These elements, including microRNAs and synonymous SNPs, contribute to CFTR protein function and dysfunction.
• Understanding these RNA features is crucial for developing targeted therapies.

Conclusions:

• CFTR RNA biology offers promising avenues for novel therapeutic interventions.
• RNA-directed therapies can potentially address genetic defects in CF patients unresponsive to current treatments.
• Further research into CFTR mRNA regulation is essential for advancing CF care.